DE1431167U - - Google Patents

Info

Publication number
DE1431167U
DE1431167U DENDAT1431167D DE1431167DU DE1431167U DE 1431167 U DE1431167 U DE 1431167U DE NDAT1431167 D DENDAT1431167 D DE NDAT1431167D DE 1431167D U DE1431167D U DE 1431167DU DE 1431167 U DE1431167 U DE 1431167U
Authority
DE
Germany
Prior art keywords
koa
üed
ïob
ättiguttbus
zzied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1431167D
Other languages
German (de)
English (en)
Publication of DE1431167U publication Critical patent/DE1431167U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1431167D Active DE1431167U (enExample)

Publications (1)

Publication Number Publication Date
DE1431167U true DE1431167U (enExample)

Family

ID=740266

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1431167D Active DE1431167U (enExample)

Country Status (1)

Country Link
DE (1) DE1431167U (enExample)

Similar Documents

Publication Publication Date Title
CN101384272B (zh) 用于递送具有增强的药理性质的活性剂的方法和组合物
ES2236775T3 (es) Formulacion de liberacion sostenida que contiene colageno y glocosaminoglucano.
AU777300B2 (en) Methods for treating congestive heart failure
US8916616B2 (en) Multi-functional polymeric materials and their uses
Krewson et al. Distribution of nerve growth factor following direct delivery to brain interstitium
Hoshimaru et al. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study
CA2184242C (en) Drug targeting system, method for preparing same and its use
DE69428992T2 (de) Immunologische verbesserung mit intermittierender interleukin-2 therapie
RU2316337C2 (ru) КОМБИНИРОВАННАЯ ТЕРАПИЯ, ИСПОЛЬЗУЮЩАЯ АНТИАНГИОГЕННЫЕ СРЕДСТВА И TNF-α
DE1431167U (enExample)
DE1213032T1 (de) Behandlung von Krankheiten durch ortsspezifische Instillation von Zellen oder ortsspezifischer Transformation von Zellen sowie Ausrüstung dafür
US11723956B2 (en) Immunomodulation after locoregional anti-tumoral treatment
CA2449288C (en) Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
US20250152501A1 (en) Dissolving microneedle for transdermal delivery of biopharmaceutical, and manufacturing method therefor
Reddan et al. Aqueous humor from traumatized eyes triggers cell division in the epithelia of cultured lenses
CN116867509A (zh) 用于葡萄糖响应性胰岛素递送的可注射可生物降解的聚合物复合物
Pan et al. Spinal cord injury changes cytokine transport
WO2009012443A1 (en) Nanoparticles for the elution of growth factors for recovery and regeneration of organs
WO2020194034A1 (en) Nanoparticle of chitosan and cyclodextrin containing encapsulated interferon and pharmaceutical compositions that contain it
Maeda et al. Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor‐α and‐β: an in vitro and in vivo study
KR20140015264A (ko) 서방성 의약 조성물
Egawa et al. 387 In-vivo analysis of bacterial antigen delivery dynamics and T cell immunity against Staphylococcus aureus skin infection
Bobak Effects of perioperative human granulocyte colony-stimulating factor on immune function and perioperative infections in patients undergoing abdominal surgery
DE1388393U (enExample)
HK1157243A (en) Methods for treating congestive heart failure